XRAY Quote, Financials, Valuation and Earnings

Align Technology has a net margin of -47.51% compared to Dentsply Sirona's net margin of 10.43%. Dentsply Sirona's return on equity of -32.39% beat Align Technology's return on equity of 11.12%.

Dentsply Sirona has a consensus price target of $20.00, signalling upside risk potential of 46.95%. On the other hand Align Technology has an analysts' consensus of $249.30 which suggests that it could grow by 61.63%. Given that Align Technology has higher upside potential than Dentsply Sirona, analysts believe Align Technology is more attractive than Dentsply Sirona.

Dentsply Sirona has a beta of 0.918, which suggesting that the stock is 8.232% less volatile than S&P 500. In comparison Align Technology has a beta of 1.728, suggesting its more volatile than the S&P 500 by 72.834%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.7%. Align Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Align Technology pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are smaller than Align Technology quarterly revenues of $995.2M. Dentsply Sirona's net income of -$430M is lower than Align Technology's net income of $103.8M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Align Technology's PE ratio is 27.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.73x versus 2.89x for Align Technology. Usually stocks with elevated PS ratios are considered overvalued.

DexCom has a net margin of -47.51% compared to Dentsply Sirona's net margin of 13.62%. Dentsply Sirona's return on equity of -32.39% beat DexCom's return on equity of 26.6%.

Dentsply Sirona has a consensus price target of $20.00, signalling upside risk potential of 46.95%. On the other hand DexCom has an analysts' consensus of $101.79 which suggests that it could grow by 64.71%. Given that DexCom has higher upside potential than Dentsply Sirona, analysts believe DexCom is more attractive than Dentsply Sirona.

Dentsply Sirona has a beta of 0.918, which suggesting that the stock is 8.232% less volatile than S&P 500. In comparison DexCom has a beta of 1.500, suggesting its more volatile than the S&P 500 by 49.959%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.7%. DexCom offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. DexCom pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are smaller than DexCom quarterly revenues of $1.1B. Dentsply Sirona's net income of -$430M is lower than DexCom's net income of $151.7M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while DexCom's PE ratio is 43.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.73x versus 6.32x for DexCom. Usually stocks with elevated PS ratios are considered overvalued.

Henry Schein has a net margin of -47.51% compared to Dentsply Sirona's net margin of 2.95%. Dentsply Sirona's return on equity of -32.39% beat Henry Schein's return on equity of 7.8%.

Dentsply Sirona has a consensus price target of $20.00, signalling upside risk potential of 46.95%. On the other hand Henry Schein has an analysts' consensus of $79.38 which suggests that it could grow by 19.21%. Given that Dentsply Sirona has higher upside potential than Henry Schein, analysts believe Dentsply Sirona is more attractive than Henry Schein.

Dentsply Sirona has a beta of 0.918, which suggesting that the stock is 8.232% less volatile than S&P 500. In comparison Henry Schein has a beta of 0.844, suggesting its less volatile than the S&P 500 by 15.587%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.7%. Henry Schein offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Henry Schein pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are smaller than Henry Schein quarterly revenues of $3.2B. Dentsply Sirona's net income of -$430M is lower than Henry Schein's net income of $94M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Henry Schein's PE ratio is 21.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.73x versus 0.67x for Henry Schein. Usually stocks with elevated PS ratios are considered overvalued.

Envista Holdings has a net margin of -47.51% compared to Dentsply Sirona's net margin of 0.18%. Dentsply Sirona's return on equity of -32.39% beat Envista Holdings's return on equity of -32.33%.

Dentsply Sirona has a consensus price target of $20.00, signalling upside risk potential of 46.95%. On the other hand Envista Holdings has an analysts' consensus of $21.33 which suggests that it could grow by 32.51%. Given that Dentsply Sirona has higher upside potential than Envista Holdings, analysts believe Dentsply Sirona is more attractive than Envista Holdings.

Dentsply Sirona has a beta of 0.918, which suggesting that the stock is 8.232% less volatile than S&P 500. In comparison Envista Holdings has a beta of 1.120, suggesting its more volatile than the S&P 500 by 12.044%.

Dentsply Sirona has a quarterly dividend of $0.16 per share corresponding to a yield of 4.7%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Dentsply Sirona pays -13.85% of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

Dentsply Sirona quarterly revenues are $905M, which are larger than Envista Holdings quarterly revenues of $652.9M. Dentsply Sirona's net income of -$430M is lower than Envista Holdings's net income of $1.2M. Notably, Dentsply Sirona's price-to-earnings ratio is -- while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Dentsply Sirona is 0.73x versus 1.11x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.